Advertisement

Glomus Tumor Pathology Guide: Diagnosis, Histology & Treatment

Comprehensive pathology of glomus tumours: from clinical features to advanced diagnostic techniques and management strategies.

By Medha deb
Created on

Introduction

Glomus tumours represent a distinctive group of vascular neoplasms originating from the glomus body, a specialised arteriovenous anastomosis involved in thermoregulation. These rare lesions account for less than 2% of all soft tissue tumours and characteristically present with disproportionate pain, particularly in response to cold or pressure. The glomus body, also known as the Sucquet-Hoyer canal, comprises modified smooth muscle cells (glomus cells) surrounding capillary-like vessels, enabling rapid blood flow modulation to regulate skin temperature.

While predominantly benign, glomus tumours exhibit a spectrum of morphological variants and rare malignant potential. Understanding their pathology is crucial for accurate diagnosis, as clinical suspicion often prompts biopsy confirmation. This article systematically reviews the clinicopathological features, histological patterns, ancillary studies, and management principles of glomus tumours.

Clinical features

Glomus tumours typically manifest as solitary, small (<1 cm) reddish-blue to purple papules or nodules, most commonly in the subungual region (50-65% of cases), particularly under fingernails of young adults. Women predominate in subungual presentations (female:male ratio up to 9:1), while extra-nail lesions show no sex predilection.

The cardinal symptom is severe, paroxysmal pain disproportionate to lesion size, exacerbated by cold exposure, pressure, or minor trauma. Cold sensitivity relates to the thermoregulatory function of glomus cells, which contract abnormally in tumours. Multiple tumours occur in 10% of cases, often familial and linked to GLMN gene mutations causing glomuvenous malformations.

  • Classic triad: localised tenderness, cold sensitivity, pinpoint erythema
  • Subungual location: nail plate ridging, dystrophy, or bone erosion on X-ray (20-40%)
  • Extracutaneous sites (rare): stomach (most common visceral), lung, bone, nerve, genitourinary tract

Diagnostic clues include the Love’s pin test (pain on pinpoint pressure) and Hildreth sign (pain relief with tourniquet ischaemia). MRI shows well-defined masses with high T2 signal; ultrasound reveals vascular flow.

Histopathology

Glomus tumours demonstrate characteristic architectural patterns comprising branching capillary-like vessels surrounded by uniform glomus cells. Three main histological variants exist, often blending within the same lesion.

Solid glomus tumour

The prototypic pattern features sheets of uniform glomus cells encircling capillary-sized vessels. Glomus cells appear as round to cuboidal cells with punched-out central nuclei, eosinophilic cytoplasm, and well-defined borders, resembling modified smooth muscle cells. High nuclear-cytoplasmic ratio and minimal atypia predominate. Vascular channels comprise 10-30% of the lesion.

Glomangioma

This vascular variant shows dilated, cavernous vascular spaces lined by a single layer of flattened endothelial cells, with glomus cells concentrated in thin walls. Staghorn configuration predominates, comprising >50% vascular component. More common in multiple/familial cases.

Glomangiomyoma

Intermediate morphology with prominent smooth muscle bundles intermixed with glomus cells and vascular channels. Least common variant.

Mitotic activity is typically absent (<5 mitoses/50 HPF); surface ulceration is rare. Bone erosion, when present, shows reactive osteoid without invasion.

Histopathology images

  • Low power: well-circumscribed nodule with vascular pattern
  • Medium power: glomus cells surrounding capillaries (solid variant)
  • High power: uniform glomus cells with round nuclei, eosinophilic cytoplasm
  • Glomangioma: dilated vascular spaces with thin glomus cell rims

Cytology images

Cytological smears reveal branching capillary fragments mantled by cohesive clusters of uniform round cells with bland nuclei and moderate eosinophilic cytoplasm. Vascular cores confirm glomus origin.

Electron microscopy

Ultrastructural analysis reveals glomus cells with features of modified smooth muscle cells:

  • Abundant thin filaments with dense bodies
  • Pinocytotic vesicles
  • Basal lamina surrounding individual cells
  • Laminar bodies and myofilaments confirming smooth muscle differentiation

Endothelial cells show typical Weibel-Palade bodies.

Immunohistochemistry

Glomus tumours display consistent immunophenotype confirming perivascular myoid differentiation:

MarkerStaining PatternSignificance
SMA (smooth muscle actin)Strong diffuse +Hallmark of smooth muscle differentiation
CalponinStrong +Myoid differentiation
Collagen IVBasal lamina +Pericellular distribution
VimentinDiffuse +Mesenchymal marker
DesminVariable/weak ±Often negative
CD34Vascular endothelium onlyNegative in glomus cells
CD31Vascular endothelium onlyNegative in glomus cells

Ki67 proliferation index <5%; p53 wild-type expression.

Genetics

Familial multiple glomus tumours (glomangiomas) show autosomal dominant inheritance due to GLMN (glomulin) mutations on 1p21-22, with somatic second hits via uniparental disomy in 70%. Sporadic tumours lack consistent mutations. NF1-associated digital glomus tumours show biallelic NF1 inactivation. Malignant variants may harbour MYH9-USP6 fusions (rare).

Prognosis and predictive factors

Solitary glomus tumours show >95% cure rate post-excision, with 5-10% local recurrence due to incomplete removal. Multiple lesions recur more frequently. Criteria for malignancy (rare, <1%):

  • Size >1 cm
  • Deep location
  • Atypia ± mitoses >5/50 HPF
  • Atypical mitoses
  • Moderate-high atypia

Malignant tumours metastasise in 40% (cutaneous/subcutaneous least aggressive).

Differential diagnosis

DiagnosisKey Distinguishing Features
HaemangiomaLacks glomus cells; CD34+ vessels
AngioleiomyomaDesmin+; mature smooth muscle bundles
Eccrine spiradenomaDuctal differentiation; cytokeratins
LeiomyomaLong fascicles; desmin+; less vascular
Clear cell acanthomaEpidermal origin; psoriasiform
Malignant variants: angiosarcomaDissection; pleomorphism; mitoses

Investigations

  • Imaging: MRI (T2 hyperintense mass); US (vascular flow); X-ray (bone erosion)
  • Biopsy: punch/excisional preferred over shave
  • Ancillary: IHC panel (SMA, calponin, collagen IV)

Management

Surgical excision remains gold standard, achieving >90% cure rate. Complete margin-negative excision essential for subungual lesions, often requiring partial nail avulsion.

  • Alternatives: sclerotherapy, laser ablation (Nd:YAG, CO2), electrocoagulation
  • Multiple tumours: segmental excision or laser
  • Malignant: wide excision ± lymph node dissection

Postoperative pain relief immediate; recurrence monitored clinically/radiologically.

Frequently asked questions

What causes the severe pain in glomus tumours?

Pain derives from abnormal contraction of glomus cells around vascular channels, amplified by cold/pressure. Nerve fibres within the lesion contribute.

Can glomus tumours be malignant?

Malignant glomus tumours are rare (<1%), defined by size >1cm, deep location, atypia, and mitoses. They show 40% metastatic potential.

Is surgical excision always required?

Solitary symptomatic tumours warrant excision. Asymptomatic or multiple lesions may be managed conservatively or with non-surgical ablation.

What is the recurrence rate after surgery?

5-15%, highest with subungual/incomplete excision. Multiple tumours recur more frequently.

Are familial glomus tumours different?

Yes, typically multiple glomangiomas due to GLMN mutations, more superficial/platy, less painful than solitary solid variants.

References

  1. Glomus tumours — DermNet NZ. Updated 2024. https://dermnetnz.org/topics/glomus-tumour
  2. Soft tissue and bone tumours — WHO Classification of Tumours Editorial Board, IARC. 2020-05-01. https://tumourclassification.iarc.who.int/chapters/33/
  3. Glomus Tumor — Musculoskeletal Tumor Society (MSTS). Accessed 2024. https://www.msts.org/glomus-tumor
  4. Glomus Tumor – Pathology — Orthobullets. Updated 2024. https://www.orthobullets.com/pathology/8075/glomus-tumor
  5. Glomus Tumour — Primary Care Dermatology Society (PCDS). Updated 2024. https://www.pcds.org.uk/clinical-guidance/glomus-tumour
Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb